4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
SciSparc Ltd. (SPRC) operates in the Biotechnology industry and is headquartered in Tel Aviv-Yafo, Israel with about 3 employees. Its market capitalization is roughly $3 million. In the fiscal year ended 2025-12-31, SPRC reported $1M in revenue and ($12M) in net income.
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.
Interactive charts & full statements → Open the SPRC valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $3M | $1M | — |
| Gross Profit | $1M | $0M | $2M | $1M | — |
| Operating Income (EBIT) | ($9M) | ($7M) | ($6M) | ($8M) | — |
| Net Income | ($12M) | ($6M) | ($5M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $8M | $10M | $11M | $11M | — |
| Total Liabilities | $2M | $1M | $2M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SPRC viewer.
About TickerBase · Data methodology & sources